e.g. mhealth
Search Results (1 to 10 of 398 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 94 Journal of Medical Internet Research
- 78 JMIR Research Protocols
- 78 JMIR mHealth and uHealth
- 57 JMIR Formative Research
- 20 JMIR Public Health and Surveillance
- 10 JMIR Diabetes
- 10 JMIR Pediatrics and Parenting
- 8 Interactive Journal of Medical Research
- 7 JMIR Medical Informatics
- 7 JMIR Serious Games
- 5 JMIR Human Factors
- 5 JMIRx Med
- 4 Iproceedings
- 4 JMIR Dermatology
- 3 JMIR Mental Health
- 2 JMIR Cancer
- 1 JMIR AI
- 1 JMIR Aging
- 1 JMIR Cardio
- 1 JMIR Infodemiology
- 1 JMIR Medical Education
- 1 JMIR Rehabilitation and Assistive Technologies
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 Journal of Participatory Medicine
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
It should be mentioned, in the 2017‐2019 wave, BMI classification adhered to the standards outlined by the International Obesity Task Force [20] (1=thinness, 2=normal weight, 3=overweight, 4=obesity). For further analysis, excess weight (ie, overweight or obesity) was determined as follows: 0=no excess weight (ie, thinness or normal weight); 1=excess weight (ie, overweight or obesity).
JMIR Public Health Surveill 2025;11:e67960
Download Citation: END BibTex RIS
Obesity, an “abnormal or excessive accumulation of fat that poses a health risk” [1], is a primary contributor to global health challenges [2]. Reports suggest its involvement in up to 80% of cases of type 2 diabetes and 43% of cardiovascular incidents [3] while significantly contributing to depression and anxiety [4].
Recent breakthroughs in bariatric medicine have elevated the role of injectable therapy, namely glucagon-like peptide-1 agonist agents such as semaglutide.
JMIR Diabetes 2025;10:e63503
Download Citation: END BibTex RIS
For example, adults with obesity, type 1 or type 2 diabetes, skin diseases, HIV, chronic pain, and cancers face pervasive stigma for their health conditions [1,4-6].
In addition to experiencing stigma from other people, negative attitudes can be internalized by adults with these health conditions, contributing to self-blame and self-devaluation (ie, self-stigma) [7,8].
JMIR Form Res 2025;9:e69548
Download Citation: END BibTex RIS
According to a report by the World Obesity Federation, more than half of the world’s population will be overweight or obese by 2035 [1]. Excess abdominal fat is a primary determinant for developing insulin resistance and other metabolic disorders [2]. Lifestyle modification is the most recommended approach for treating and preventing obesity at any stage of life [2].
JMIR Res Protoc 2025;14:e71829
Download Citation: END BibTex RIS
Obesity and mental health problems are intricately connected, with evidence suggesting a bidirectional relationship between the two [1,2]. Depression, one of the most extensively studied mental health issues, increases the risk of obesity by 58%, while obesity elevates the risk of depression by 55% [3]. Furthermore, both obesity and depression are significant risk factors for reduced work ability [4,5], and occupational burnout has been linked to these conditions [6-8].
JMIR Ment Health 2025;12:e66518
Download Citation: END BibTex RIS
Obesity remains a global health crisis, affecting 890 million adults worldwide and contributing to diseases such as type 2 diabetes, cardiovascular disease, and certain cancers [1]. In the United Kingdom, projections suggest that by 2050, the annual cost of obesity to the National Health Service (NHS) could reach £9.7 billion (US $12.1 billion), with wider societal expenses approaching £49.9 billion (US $62.4 billion) [2].
JMIR Form Res 2025;9:e72577
Download Citation: END BibTex RIS
Virtual Reality in Obesity Management: Addressing Key Limitations in Clinical Application
We are writing to express our appreciation for the recent publication in the Journal of Medical Internet Research titled “Assessing the Clinical Efficacy of a Virtual Reality Tool for the Treatment of Obesity: Randomized Controlled Trial” [1]. The authors propose an innovative approach to obesity treatment that leverages the interactivity and immersive experience of virtual reality (VR) technology through a randomized controlled trial, providing new scientific evidence for obesity management.
J Med Internet Res 2025;27:e68269
Download Citation: END BibTex RIS
The burden of diabetes and obesity are greater for racial-ethnic minority groups in the United States, including non-Hispanic Blacks [1,2]. Estimates (2019‐2021) of the prevalence of diagnosed diabetes in the United States indicate that 12.5% of Black non-Hispanic adults (>18 years) have diabetes compared with 8.5% of white non-Hispanic adults [3]. Obesity is a major risk factor for the development of type 2 diabetes mellitus (T2 DM).
JMIR Form Res 2025;9:e64051
Download Citation: END BibTex RIS
Over the past 4 decades, there has been a dramatic increase in obesity and related diseases, with approximately 50% of adults in China having overweight or obesity [1]. By 2030, the number of individuals with overweight or obesity in China is predicted to increase to 790 million, and the medical costs associated with overweight and obesity are expected to reach US $61 billion [2].
J Med Internet Res 2025;27:e65868
Download Citation: END BibTex RIS
We obtained the state obesity rate data from the Behavioral Risk Factor Surveillance System (BRFSS). BRFSS provided the ground truth for the prevalence of obesity via self-reported obesity data among US adults by state and territory in 2019, 2020, and 2021. In Figure 3, we classified 49 states into 4 different obesity levels based on the state obesity rate. New Jersey was excluded from this study because the obesity rate data from BRFSS for New Jersey were missing due to insufficient data.
J Med Internet Res 2025;27:e51638
Download Citation: END BibTex RIS